Um estudo de nemtabrutinibe mais venetoclax versus venetoclax + rituximabe (VR) em leucemia linfocítica crônica/linfoma linfocítico de pequenas células (LLC/LLPC) de segunda linha (2L) + recidivante/refratária (R/R)
The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study